Clinical Trial Update: Pharmacokinetics and Safety of Roledumab in RhD-negative Pregnant Women Carrying an RhD-positive Foetus [Phase 2]

View source ↗

Summary

Phase 2 study assessing pharmacokinetics and safety of Roledumab in RhD-negative pregnant women with an RhD-positive fetus; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rh Disease

Drugs mentioned

• Roledumab (Roledumab)

Snippet

Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Rh Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-08-16